{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360004236406469120.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1159/000440625"}},{"identifier":{"@type":"URI","@value":"https://www.karger.com/Article/Pdf/440625"}},{"identifier":{"@type":"URI","@value":"https://karger.com/ocl/article-pdf/89/Suppl.%202/4/4005873/000440625.pdf"}},{"identifier":{"@type":"PMID","@value":"26584030"}}],"resourceType":"学術雑誌論文(journal article)","dc:title":[{"@value":"Evaluation of ART Scores for Repeated Transarterial Chemoembolization in Japanese Patients with Hepatocellular Carcinoma"}],"description":[{"type":"abstract","notation":[{"@value":"<jats:p>Objective: Transarterial chemoembolization (TACE) is recommended as a first-line therapy for hepatocellular carcinoma (HCC) patients ineligible for curative therapy and without portal invasion. The Assessment for Retreatment with TACE (ART) scoring system was recently proposed for identifying patients who would not show sufficient survival benefit from repeated TACE. We reevaluated the performance of ART in HCC patients treated in Japan, where selective TACE is commonly used. Methods: Between 2000 and 2013, 988 patients with HCC underwent TACE at Kinki University Hospital, and 627 received ≥2 sessions of TACE. Seventy-six patients who underwent ≥2 TACE sessions within 90 days were investigated for their performance of the ART score in the context of overall survival (OS). Results: Only 12% (76/627) of patients underwent ≥2 TACE sessions within 90 days. Of those, 52 patients showed a low ART score (0-1.5), and 24 had a high ART score (≥2.5); the median OS was 20.2 and 37.6 months, respectively (p = 0.8207). Conclusion: The ART scoring system did not demonstrate a sufficiently predictive impact on OS among the patients who underwent ≥2 TACE sessions within 90 days. Application of the ART score should be carefully considered because differences in TACE procedures and post-TACE treatment can affect the results while evaluating OS.</jats:p>"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380004236406469122","@type":"Researcher","foaf:name":[{"@value":"Tadaaki Arizumi"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004236406469126","@type":"Researcher","foaf:name":[{"@value":"Kazuomi Ueshima"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004236406469120","@type":"Researcher","foaf:name":[{"@value":"Mina Iwanishi"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004236406469253","@type":"Researcher","foaf:name":[{"@value":"Tomohiro Minami"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004236406469128","@type":"Researcher","foaf:name":[{"@value":"Hirokazu Chishina"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004236406469123","@type":"Researcher","foaf:name":[{"@value":"Masashi Kono"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004236406469252","@type":"Researcher","foaf:name":[{"@value":"Masahiro Takita"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004236406469250","@type":"Researcher","foaf:name":[{"@value":"Satoshi Kitai"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004236406469251","@type":"Researcher","foaf:name":[{"@value":"Tatsuo Inoue"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004236406469127","@type":"Researcher","foaf:name":[{"@value":"Norihisa Yada"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004236406469121","@type":"Researcher","foaf:name":[{"@value":"Satoru Hagiwara"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004236406469254","@type":"Researcher","foaf:name":[{"@value":"Hiroshi Ida"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004236406469125","@type":"Researcher","foaf:name":[{"@value":"Yasunori Minami"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004236406469124","@type":"Researcher","foaf:name":[{"@value":"Toshiharu Sakurai"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004236406469248","@type":"Researcher","foaf:name":[{"@value":"Naoshi Nishida"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004236406469249","@type":"Researcher","foaf:name":[{"@value":"Masayuki Kitano"}]},{"@id":"https://cir.nii.ac.jp/crid/1420001326228141184","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"10298953"},{"@type":"NRID","@value":"1000010298953"},{"@type":"CINII_AUTHOR_ID","@value":"DA13185849"},{"@type":"URI","@value":"https://ci.nii.ac.jp/author/DA13185849#entity"},{"@type":"URI","@value":"https://viaf.org/viaf/NII%7CDA13185849"},{"@type":"NRID","@value":"9000002288775"},{"@type":"NRID","@value":"9000001231969"},{"@type":"NRID","@value":"9000326268159"},{"@type":"NRID","@value":"9000021508006"},{"@type":"NRID","@value":"9000021344323"},{"@type":"NRID","@value":"9000021215576"},{"@type":"NRID","@value":"9000243897150"},{"@type":"NRID","@value":"9000414080446"},{"@type":"NRID","@value":"9000011225470"},{"@type":"NRID","@value":"9000022058120"},{"@type":"NRID","@value":"9000409991695"},{"@type":"NRID","@value":"9000391398432"},{"@type":"NRID","@value":"9000368418351"},{"@type":"NRID","@value":"9000313200385"},{"@type":"NRID","@value":"9000314382594"},{"@type":"NRID","@value":"9000402399814"},{"@type":"NRID","@value":"9000255795525"},{"@type":"NRID","@value":"9000256329907"},{"@type":"NRID","@value":"9000018365907"},{"@type":"NRID","@value":"9000021349489"},{"@type":"NRID","@value":"9000021217898"},{"@type":"NRID","@value":"9000345293607"},{"@type":"NRID","@value":"9000346922598"},{"@type":"NRID","@value":"9000002000034"},{"@type":"NRID","@value":"9000018273321"},{"@type":"NRID","@value":"9000323295132"},{"@type":"NRID","@value":"9000402373935"},{"@type":"NRID","@value":"9000409511070"},{"@type":"NRID","@value":"9000383088636"},{"@type":"NRID","@value":"9000402008401"},{"@type":"NRID","@value":"9000403282962"},{"@type":"NRID","@value":"9000402793420"},{"@type":"NRID","@value":"9000405673425"},{"@type":"NRID","@value":"9000258017887"},{"@type":"NRID","@value":"9000256331012"},{"@type":"NRID","@value":"9000398786165"},{"@type":"NRID","@value":"9000000756797"},{"@type":"NRID","@value":"9000021446344"},{"@type":"NRID","@value":"9000021235381"},{"@type":"NRID","@value":"9000021270324"},{"@type":"NRID","@value":"9000411489668"},{"@type":"NRID","@value":"9000399808239"},{"@type":"NRID","@value":"9000283677980"},{"@type":"NRID","@value":"9000383216612"},{"@type":"NRID","@value":"9000000902442"},{"@type":"NRID","@value":"9000021433225"},{"@type":"NRID","@value":"9000020472894"},{"@type":"NRID","@value":"9000369353922"},{"@type":"NRID","@value":"9000412226231"},{"@type":"NRID","@value":"9000401807534"},{"@type":"NRID","@value":"9000409632730"},{"@type":"NRID","@value":"9000256894198"},{"@type":"NRID","@value":"9000018461756"},{"@type":"NRID","@value":"9000020126597"},{"@type":"NRID","@value":"9000021277636"},{"@type":"NRID","@value":"9000378112144"},{"@type":"NRID","@value":"9000398794726"},{"@type":"NRID","@value":"9000255798680"},{"@type":"NRID","@value":"9000409980047"},{"@type":"NRID","@value":"9000316207441"},{"@type":"NRID","@value":"9000016402006"},{"@type":"NRID","@value":"9000021639035"},{"@type":"NRID","@value":"9000021413414"},{"@type":"NRID","@value":"9000380123839"},{"@type":"NRID","@value":"9000347129199"},{"@type":"NRID","@value":"9000410857556"},{"@type":"NRID","@value":"9000248965950"},{"@type":"NRID","@value":"9000107378774"},{"@type":"NRID","@value":"9000019088077"},{"@type":"NRID","@value":"9000020043727"},{"@type":"NRID","@value":"9000021495823"},{"@type":"NRID","@value":"9000021503246"},{"@type":"NRID","@value":"9000286623990"},{"@type":"NRID","@value":"9000398153900"},{"@type":"NRID","@value":"9000410909739"},{"@type":"NRID","@value":"9000398996622"},{"@type":"NRID","@value":"9000411264242"},{"@type":"NRID","@value":"9000329891787"},{"@type":"NRID","@value":"9000356567440"},{"@type":"NRID","@value":"9000248229061"},{"@type":"NRID","@value":"9000005840052"},{"@type":"NRID","@value":"9000021483677"},{"@type":"NRID","@value":"9000021431299"},{"@type":"NRID","@value":"9000365617592"},{"@type":"NRID","@value":"9000286629649"},{"@type":"NRID","@value":"9000347077938"},{"@type":"NRID","@value":"9000414562406"},{"@type":"NRID","@value":"9000410909755"},{"@type":"NRID","@value":"9000255797450"},{"@type":"NRID","@value":"9000018408884"},{"@type":"NRID","@value":"9000021285608"},{"@type":"NRID","@value":"9000021264950"},{"@type":"NRID","@value":"9000256353931"},{"@type":"NRID","@value":"9000405696271"},{"@type":"NRID","@value":"9000001279395"},{"@type":"NRID","@value":"9000019065611"},{"@type":"NRID","@value":"9000345298294"},{"@type":"NRID","@value":"9000258014904"},{"@type":"NRID","@value":"9000006777585"},{"@type":"NRID","@value":"9000001200538"},{"@type":"NRID","@value":"9000024340854"},{"@type":"NRID","@value":"9000022070960"},{"@type":"NRID","@value":"9000414335033"},{"@type":"NRID","@value":"9000412233250"},{"@type":"NRID","@value":"9000412375356"},{"@type":"NRID","@value":"9000000674380"},{"@type":"NRID","@value":"9000001758039"},{"@type":"NRID","@value":"9000014164155"},{"@type":"NRID","@value":"9000248228528"},{"@type":"NRID","@value":"9000018235735"},{"@type":"NRID","@value":"9000107335996"},{"@type":"NRID","@value":"9000021452455"},{"@type":"NRID","@value":"9000382215534"},{"@type":"NRID","@value":"9000406310078"},{"@type":"NRID","@value":"9000411626484"},{"@type":"NRID","@value":"9000242669306"},{"@type":"NRID","@value":"9000411272133"},{"@type":"NRID","@value":"9000000503356"},{"@type":"NRID","@value":"9000248228651"},{"@type":"NRID","@value":"9000259329186"},{"@type":"NRID","@value":"9000021483051"},{"@type":"NRID","@value":"9000347181648"},{"@type":"NRID","@value":"9000403282864"},{"@type":"NRID","@value":"9000408451895"},{"@type":"NRID","@value":"9000399376038"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/m-kudo"}],"foaf:name":[{"@value":"Masatoshi Kudo"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00302414"},{"@type":"EISSN","@value":"14230232"}],"prism:publicationName":[{"@value":"Oncology"}],"dc:publisher":[{"@value":"S. Karger AG"}],"prism:publicationDate":"2015","prism:volume":"89","prism:number":"Suppl. 2","prism:startingPage":"4","prism:endingPage":"10"},"reviewed":"false","dc:rights":["https://karger.com/pages/terms-and-conditions","https://karger.com/pages/terms-and-conditions"],"url":[{"@id":"https://www.karger.com/Article/Pdf/440625"},{"@id":"https://karger.com/ocl/article-pdf/89/Suppl.%202/4/4005873/000440625.pdf"}],"createdAt":"2015-11-18","modifiedAt":"2025-04-23","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=Male","dc:title":"Male"},{"@id":"https://cir.nii.ac.jp/all?q=Carcinoma,%20Hepatocellular","dc:title":"Carcinoma, Hepatocellular"},{"@id":"https://cir.nii.ac.jp/all?q=Liver%20Neoplasms","dc:title":"Liver Neoplasms"},{"@id":"https://cir.nii.ac.jp/all?q=Middle%20Aged","dc:title":"Middle Aged"},{"@id":"https://cir.nii.ac.jp/all?q=Prognosis","dc:title":"Prognosis"},{"@id":"https://cir.nii.ac.jp/all?q=Decision%20Support%20Techniques","dc:title":"Decision Support Techniques"},{"@id":"https://cir.nii.ac.jp/all?q=Cohort%20Studies","dc:title":"Cohort Studies"},{"@id":"https://cir.nii.ac.jp/all?q=Survival%20Rate","dc:title":"Survival Rate"},{"@id":"https://cir.nii.ac.jp/all?q=Japan","dc:title":"Japan"},{"@id":"https://cir.nii.ac.jp/all?q=Outcome%20Assessment,%20Health%20Care","dc:title":"Outcome Assessment, Health Care"},{"@id":"https://cir.nii.ac.jp/all?q=Retreatment","dc:title":"Retreatment"},{"@id":"https://cir.nii.ac.jp/all?q=Humans","dc:title":"Humans"},{"@id":"https://cir.nii.ac.jp/all?q=Infusions,%20Intra-Arterial","dc:title":"Infusions, Intra-Arterial"},{"@id":"https://cir.nii.ac.jp/all?q=Female","dc:title":"Female"},{"@id":"https://cir.nii.ac.jp/all?q=Chemoembolization,%20Therapeutic","dc:title":"Chemoembolization, Therapeutic"},{"@id":"https://cir.nii.ac.jp/all?q=Aged","dc:title":"Aged"},{"@id":"https://cir.nii.ac.jp/all?q=Follow-Up%20Studies","dc:title":"Follow-Up Studies"},{"@id":"https://cir.nii.ac.jp/all?q=Neoplasm%20Staging","dc:title":"Neoplasm Staging"}],"project":[{"@id":"https://cir.nii.ac.jp/crid/1040282256826997504","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"15K09028"},{"@type":"JGN","@value":"JP15K09028"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-15K09028/"}],"notation":[{"@language":"ja","@value":"血清分泌型マイクロRNAを用いたソラフェニブ治療効果予測マーカーの開発"},{"@language":"en","@value":"Development of biomarker for sorafenib treatment using serum microRNA in patients with hepatocellular carcinoma"}]}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360002218707574656","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011143628999424","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011146361971584","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Tumor Markers for Hepatocellular Carcinoma: Simple and Significant Predictors of Outcome in Patients with HCC"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285711379263872","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Validation of the Criteria of Transcatheter Arterial Chemoembolization Failure or Refractoriness in Patients with Advanced Hepatocellular Carcinoma Proposed by the LCSGJ"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292621559417088","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Hong Kong Consensus Recommendations on the Management of Hepatocellular Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294646783496064","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Phase I Trial of Sorafenib Following Liver Transplantation in Patients with High-Risk Hepatocellular Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294647255182720","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Tracking Navigation Imaging of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Using Three-Dimensional Cone-Beam CT Angiography"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298342042699136","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Chemoembolization for Hepatocellular Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565168659995008","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574095856671488","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Estimating the world cancer burden: Globocan 2000"}]},{"@id":"https://cir.nii.ac.jp/crid/1360579817762531200","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The Size of the Problem: Clinical Algorithms"}]},{"@id":"https://cir.nii.ac.jp/crid/1360579817798004480","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Treatment Algorithm for Intermediate and Advanced Stage Hepatocellular Carcinoma: Korea"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857596541535360","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Drug Therapy for Advanced-Stage Liver Cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861294435691136","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The ART Score Is Not Effective to Select Patients for Transarterial Chemoembolization Retreatment in an Italian Series"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137043914523776","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Surgical and Locoregional Therapy of HCC: TACE"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137045125383552","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Treatment of Hepatocellular Carcinoma: A Systematic Review"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418519582312704","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Epidemiology and Surveillance of Hepatocellular Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418519915345024","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699995099775232","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Hepatocellular Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699995845397760","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Chemoembolization in Patients with Hepatocellular Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262943872195712","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262944711158528","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"How to Define Transarterial Chemoembolization Failure or Refractoriness: A European Perspective"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825896164746880","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Efficacy of Sorafenib in Intermediate-Stage Hepatocellular Carcinoma Patients Refractory to Transarterial Chemoembolization"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388845514738944","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Management of Hepatocellular Carcinoma: An Update Δσ"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388845850655104","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388846169209856","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670319805932800","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Treatment strategies for hepatocellular carcinoma in Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670320165570944","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Clinical Practice Guidelines for Hepatocellular Carcinoma Differ between Japan, United States, and Europe"}]},{"@id":"https://cir.nii.ac.jp/crid/1363949023325829120","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Hepatic arterial embolization for unresectable hepatocellular carcinomas: do technical factors affect prognosis?"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951795702874368","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Chemoembolization for hepatocellular carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233268225128960","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Surveillance, Diagnosis, Treatment, and Outcome of Liver Cancer in Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233268667356928","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Locoregional Therapy for Hepatocellular Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233268784657152","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Transarterial Chemoembolization Failure/Refractoriness: JSH-LCSGJ Criteria 2014 Update"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233270511533184","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Asian Consensus Workshop Report: Expert Consensus Guideline for the Management of Intermediate and Advanced Hepatocellular Carcinoma in Asia"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1159/000440625"},{"@type":"KAKEN","@value":"PRODUCT-20197093"},{"@type":"OPENAIRE","@value":"doi_dedup___::995fab15af255ad321de1e50a4d65acd"}]}